RIVAROXABAN TEVA 10 MG TBL FLM 100X1

Show dosage form

What is the maximum co-payment for RIVAROXABAN TEVA?

If the insurance company contributes, the maximum co-payment is 4 776,84 Kč. The maximum pharmacy price is 5 891,61 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does RIVAROXABAN TEVA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

1 114,77 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Přípravek je v ambulantní péči hrazen v primární prevenci žilních tromboembolií u dospělých pacientů, kteří podstoupili elektivní operativní totální náhradu kyčelního nebo kolenního kloubu. Maximální celková doba podávání hrazená ze zdravotního pojištění po elektivní náhradě kolenního kloubu je 14 dní, po elektivní náhradě kyčelního kloubu 28-35 dní.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe RIVAROXABAN TEVA?

Prescription is not conditional on a medical specialization.

What is the composition of RIVAROXABAN TEVA?

Rivaroxaban (10 mg), natrium-lauryl-sulfát, monohydrát laktosy, hypromelosa, sodná sůl kroskarmelosy, magnesium-stearát, neznámá látka s kódem 17846, oxid titaničitý, makrogol 3350, ointmentek, neznámá látka s kódem 391, žlutý oxid železitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to RIVAROXABAN TEVA?

The medicine belongs to ATC group B01AF01 – RIVAROXABAN. Medicines with the same active substance can be found here.

Who manufactures RIVAROXABAN TEVA?

Teva Pharmaceuticals CR, s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 13. 6. 2024. Production was interrupted as of 13. 6. 2024. The stated reason was: Výrobní důvody.
Resumption of supply is expected 31. 1. 2026
The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for RIVAROXABAN TEVA?

The medicine has code 0273535. Code details can be found here.

How many packs of RIVAROXABAN TEVA were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of RIVAROXABAN TEVA were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

PODOBNÉ PŘÍPRAVKY:

The page was last updated on 07. 01. 2026

SIMILAR MEDICINES: